SCHEMBL3743465

SCHEMBL3743465

CC(=CC1=C(Cl)C(=O)c2ccccc2C1=O)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 13/20 1.00
AKR1C3 P42330 1/20 0.49
HSP90AA1 P07900 2/20 0.47
HSP90AB1 P08238 2/20 0.47
IDO1 P14902 1/20 0.47
DNMT1 P26358 1/20 0.47
DNMT3L Q9UJW3 1/20 0.47
DNMT3A Q9Y6K1 1/20 0.47
PTPN6 P29350 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CDC25A P30304 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3745788 1.00 APEX1 (1.00) APEX1AKR1C3HSP90AA1HSP90AB1IDO1
SCHEMBL3743461 1.00 APEX1 (1.00) APEX1AKR1C3HSP90AA1HSP90AB1IDO1
SCHEMBL13894618 0.88 APEX1 (0.78) APEX1AKR1C3HSP90AA1HSP90AB1IDO1
SCHEMBL20123280 0.88 APEX1 (0.78) APEX1AKR1C3HSP90AA1HSP90AB1IDO1
SCHEMBL13894584 0.88 APEX1 (0.78) APEX1AKR1C3HSP90AA1HSP90AB1IDO1
SCHEMBL13894609 0.86 APEX1 (0.75) APEX1HSP90AA1HSP90AB1IDO1DNMT1
SCHEMBL13049410 0.86 APEX1 (0.74) APEX1AKR1C3HSP90AA1HSP90AB1IDO1
SCHEMBL13049663 0.83 APEX1 (0.71) APEX1HSP90AA1HSP90AB1IDO1DNMT1
SCHEMBL13049412 0.83 APEX1 (0.71) APEX1HSP90AA1HSP90AB1IDO1DNMT1
SCHEMBL3748323 0.82 APEX1 (1.00) APEX1AKR1C3HSP90AA1HSP90AB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203161-B1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF UNIV INDIANA RES & TECH CORP (US) 2018-05-09 EP disclosed
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 US disclosed
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 US disclosed
EP-2203161-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF Indiana University Research and Technology Corporation (US) 2010-07-07 EP disclosed
WO-2009042544-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF APEX1, NQO1, REV1 APEX1 1/4885AKR1C3 933/4885HSP90AA1 1992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.